J.G. Chemicals Reports IPO Fund Use, Delays R&D Capex to FY27

J.G. Chemicals has submitted its Q4 FY26 Monitoring Agency Report, detailing the use of its Initial Public Offering (IPO) funds. As of March 31, 2026, the company utilized ₹131.47 crore of its IPO proceeds. However, ₹4.26 crore earmarked for its R&D Centre capital expenditure is now scheduled for deployment in FY2027. This delay stems from issues in construction works and equipment procurement. The company noted management flexibility regarding minor deviations from original vendor specifications and affirmed that its core IPO objectives remain unchanged.

This timeline shift for R&D spending signals potential execution challenges, though the company assures core IPO goals are on track. Investors typically watch for the timely use of capital for growth initiatives like R&D, as delays can affect innovation timelines.

J.G. Chemicals raised ₹251.19 crore in its March 2023 IPO (FY23) for general corporate purposes, R&D Centre capital expenditure, and working capital. The IPO prospectus had previously flagged potential challenges and delays in establishing the R&D centre.

While the fundamental purpose of the IPO remains unchanged, the delay impacts the utilization pace for specific projects. Further delays in constructing or equipping the R&D Centre could affect future innovation cycles. Management's flexibility with vendor specifications, while allowing progress, may also draw investor attention regarding execution quality.

In the specialty chemicals sector, where J.G. Chemicals operates, peers like Aarti Industries and Atul Ltd also invest heavily in R&D and capital expenditure for expansion. Timely deployment of such funds is a key factor for growth companies.

As of Q4 FY26, the company had raised ₹251.19 crore from its IPO and utilized ₹131.47 crore, leaving ₹33.53 crore unutilized. The ₹4.26 crore for R&D Centre capex is now planned for FY2027. Investors will track the actual spending on the R&D Centre in FY2027, progress on its construction and equipment, and any further updates on procurement timelines or vendor specifications in future reports.